Development and evaluation of a community-based buprenorphine treatment intervention

Development and evaluation of a community-based buprenorphine treatment intervention

Abstract Background The majority of Americans with opioid use disorder remain out of treatment. Operating in 33 states, Washington DC, and Puerto Rico, harm reduction agencies, which provide sterile syringes and other health services to people who inject drugs, are a key venue to reach out-of-treatm...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Aaron D. Fox, Nancy L. Sohler, Taeko Frost, Carolina Lopez, Chinazo O. Cunningham
Natura:	Articolo
Lingua:	English
Pubblicazione:	BMC 2017-05-01
Serie:	Harm Reduction Journal
Soggetti:	Buprenorphine Harm reduction agencies Access to care Opioid addiction
Accesso online:	http://link.springer.com/article/10.1186/s12954-017-0149-y

Documenti analoghi

Buprenorphine/naloxone initiation in the emergency department: A series of vignettes
di: Margarita Popova, et al.
Pubblicazione: (2024-12-01)

Overview of best practices for buprenorphine initiation in the emergency department
di: Terence Hughes, et al.
Pubblicazione: (2024-02-01)

Patient’s perspective on early treatment retention in take home buprenorphine maintenance treatment- an explorative study from India
di: P. M, et al.
Pubblicazione: (2021-04-01)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
di: Hassan Ziaaddini, et al.
Pubblicazione: (2018-12-01)

Patient experiences of buprenorphine dispensing from a mobile medical unit
di: Sarah E. Messmer, et al.
Pubblicazione: (2024-07-01)

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
di: Barrot H. Lambdin, et al.
Pubblicazione: (2022-07-01)

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018
di: Kevin P. Conway, et al.
Pubblicazione: (2022-01-01)

Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
di: Berkeley Franz, et al.
Pubblicazione: (2024-01-01)

First, Do No Harm: Buprenorphine Use for Pain Associated with Chronic Diseases
di: Amanda Springer, et al.
Pubblicazione: (2024-11-01)

Benefit-Risk Analysis of Buprenorphine for Pain Management
di: Hale M, et al.
Pubblicazione: (2021-05-01)

Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series
di: Taylor A. Ochalek, et al.
Pubblicazione: (2023-06-01)

Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US
di: Berkeley Franz, et al.
Pubblicazione: (2023-12-01)

Patients' perspectives on buprenorphine subcutaneous implant: a case series
di: Claudio Pierlorenzi, et al.
Pubblicazione: (2024-04-01)

Development and Implementation of Tennessee Nonresidential Buprenorphine Treatment Guidelines
di: Erica Schlesinger, et al.
Pubblicazione: (2018-10-01)

Single high-dose buprenorphine for opioid craving during withdrawal
di: Jamshid Ahmadi, et al.
Pubblicazione: (2018-12-01)

Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study
di: Jamie Carter, et al.
Pubblicazione: (2022-11-01)

Transdermal buprenorphine for pain management in children
di: Giorgio Attinà, et al.
Pubblicazione: (2021-09-01)

Adapting low-dose buprenorphine induction to meet patient needs: A pilot study
di: Zoe A. Karavolis, et al.
Pubblicazione: (2022-12-01)

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
di: Venumadhav Janganati, et al.
Pubblicazione: (2023-05-01)

Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
di: Neil B. Patel, et al.
Pubblicazione: (2024-01-01)

Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse
di: Alalade E, et al.
Pubblicazione: (2020-02-01)

County-level neonatal opioid withdrawal syndrome rates and real-world access to buprenorphine during pregnancy: An audit (“secret shopper”) study in Missouri
di: Bronwyn S. Bedrick, et al.
Pubblicazione: (2024-03-01)

Comparative Trial to Study the Effectiveness of Clonidine Hydrochloride and Buprenorphine-Naloxone in Opioid Withdrawal – A Hospital Based Study
di: Syed Sajad Hussain, et al.
Pubblicazione: (2015-01-01)

Implementation of an education session on buprenorphine induction in the emergency department, a resident-led initiative
di: Cara Marie Borelli, et al.
Pubblicazione: (2024-01-01)

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
di: Jamie Carter, et al.
Pubblicazione: (2019-05-01)

Comparison of Sleep Problems in Opioid-Dependent Patients under Methadone and Buprenorphine Treatment
di: Mehdi Madanifard, et al.
Pubblicazione: (2018-02-01)

Anxiety treatment of opioid dependent patients with buprenorphine: A randomized, double-blind, clinical trial
di: Jamshid Ahmadi, et al.
Pubblicazione: (2017-01-01)

Descriptive study: the novel “full spectrum people-with-opioid-use-disorder care model”
di: Richard Gadomski, et al.
Pubblicazione: (2023-04-01)

Role of buprenorphine in acute postoperative pain
di: J. Alcázar-Castro, et al.
Pubblicazione: (2016-07-01)

Low-dose buprenorphine initiation during pregnancy: a case report
di: Shivania Reddy, BSc, et al.
Pubblicazione: (2024-02-01)

Rationale for cannabis-based interventions in the opioid overdose crisis
di: Philippe Lucas
Pubblicazione: (2017-08-01)

Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study
di: Benjamin L. H. Jones, et al.
Pubblicazione: (2024-04-01)

A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
di: David Wiercigroch, et al.
Pubblicazione: (2021-04-01)

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
di: Travis M. Scott, et al.
Pubblicazione: (2017-11-01)

Criminal charges prior to and after initiation of office-based buprenorphine treatment
di: Harris Elizabeth E, et al.
Pubblicazione: (2012-03-01)

Commentary on physicians’ satisfaction with providing buprenorphine treatment by Knudsen et al.
di: Gavin Bart, et al.
Pubblicazione: (2019-08-01)

Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study
di: Joëlla W. Adams, et al.
Pubblicazione: (2023-10-01)

Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series
di: John P. Murray, et al.
Pubblicazione: (2023-06-01)

Opioid Substitution: More than Only Methadone!
di: M. Torrens
Pubblicazione: (2022-06-01)

The role of recovery peer navigators in retention in outpatient buprenorphine treatment: a retrospective cohort study
di: Arley Giraldo, et al.
Pubblicazione: (2024-12-01)